Related Experiment Videos
LY178002 reduces rat brain damage after transient global forebrain ischemia
J A Clemens1, P P Ho, J A Panetta
1Lilly Research Laboratories, Eli Lilly and Co., Indiannapolis, Ind 46285.
Stroke
|August 1, 1991
Summary
LY178002, a 4-thiazolidinone compound, significantly protected brain tissue from ischemia and reperfusion damage in rats. This compound also potently inhibited lipid peroxidation, suggesting a multifactorial mechanism for its neuroprotective effects.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Ischemia and reperfusion cause neuronal damage through mechanisms like oxidative stress and lipid peroxidation.
- The arachidonic acid cascade involves enzymes implicated in ischemia-induced damage.
- 4-thiazolidinone compounds, such as LY178002, are known inhibitors of key enzymes in this cascade.
Purpose of the Study:
- To evaluate the neuroprotective effects of LY178002 in a global forebrain ischemia-reperfusion model.
- To investigate LY178002's potential as an inhibitor of lipid peroxidation.
Main Methods:
- A four-vessel occlusion model of global forebrain ischemia was used in Wistar rats.
- Rats were pretreated with LY178002 at doses of 150 mg/kg and 50 mg/kg.
- Neuronal damage in the striatum and hippocampus was assessed.
- LY178002's inhibitory activity against iron-dependent lipid peroxidation was evaluated.
Main Results:
- Pretreatment with LY178002 significantly reduced striatal and hippocampal CA1 damage after ischemia-reperfusion.
- Both 150 mg/kg and 50 mg/kg doses of LY178002 demonstrated significant neuroprotection.
- LY178002 was identified as a potent inhibitor of iron-dependent lipid peroxidation.
Conclusions:
- LY178002 exhibits significant neuroprotective effects against global forebrain ischemia-reperfusion in rats.
- The compound's efficacy may stem from its ability to inhibit multiple damage pathways, including lipid peroxidation.
- LY178002 shows therapeutic potential for conditions involving ischemia-reperfusion injury.